Observing patients with ulcerative colitis in remission for recurrence
Research on the Biological Basis of "Disease-Syndrome-Formula" in the Critical State of "Remission-Recurrence" of Ulcerative Colitis (Joint Application A)
This study is tracking 100 people with ulcerative colitis who are in remission to see if their symptoms come back over six months while also checking their overall health and mood.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 100 (estimated) |
| Sex | All |
| Sponsor | Beijing Hospital of Traditional Chinese Medicine Academic / other |
| Locations | 1 site (Dongcheng, Beijing Municipality) |
| Trial ID | NCT06694883 on ClinicalTrials.gov |
What this trial studies
This observational study will recruit 100 patients diagnosed with ulcerative colitis who are currently in remission. Over a 6-month period, participants will be monitored monthly to record their symptoms, general health information, and psychological assessments related to anxiety and depression. Additionally, blood, urine, and stool samples will be collected each month for laboratory analysis. The goal is to track any recurrence of the disease during the follow-up period.
Who should consider this trial
Good fit: Ideal candidates are patients diagnosed with ulcerative colitis who are currently in remission and meet specific clinical criteria.
Not a fit: Patients with incomplete medical records or those with severe complications or coexisting diseases may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance understanding of ulcerative colitis remission and recurrence, potentially leading to better management strategies for patients.
How similar studies have performed: While observational studies on ulcerative colitis exist, this specific approach focusing on the remission-recurrence state is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients who meet the criteria based on the clinical characteristics of ulcerative colitis patients in the "remission recurrence" critical state, combined with clinical symptoms, are diagnosed with ulcerative colitis through imaging, endoscopy, laboratory, and histopathological examinations; * Patients with comprehensive laboratory testing indicators. Exclusion Criteria: * Patients with incomplete case information records; * Patients who have not completed serological tests; * Complications including intestinal obstruction, intestinal perforation, toxic megacolon, and severe local stenosis; * Diagnosed or suspected patients with coexisting uncertain colitis, infectious or ischemic colitis; * Patients with coexisting local or systemic infections, any malignant diseases, or autoimmune diseases; * Merge primary diseases such as respiratory, circulatory, neurological, endocrine, and hematological disorders; * Individuals at risk of developing cancer; * regnant or lactating women.
Where this trial is running
Dongcheng, Beijing Municipality
- Beijing Hospital of Traditional Chinese Medicine, Capital Medical University — Dongcheng, Beijing Municipality, China (Recruiting)
Study contacts
- Principal investigator: Shengsheng Zhang, Doctor — Beijing Hospital of Traditional Chinese Medicine
- Study coordinator: Danyan Li, Doctor
- Email: danyan20121027@163.com
- Phone: 15811263607
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.